English
简体中文
Total: £ 56.28
2026-03-16 | Pages: 137 | Tables: 135
The global Astaxanthin Soft Health Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-16 | Pages: 134 | Tables: 130
The global Astaxanthin Soft Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lands...
2026-03-16 | Pages: 97 | Tables: 103
The global Levodopa and Benserazide Hydrochloride Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the...
2026-03-16 | Pages: 102 | Tables: 90
The global Levodopa and Benserazide Hydrochloride Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the ...
2026-03-16 | Pages: 125 | Tables: 118
The global Capecitabine Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
2026-03-16 | Pages: 112 | Tables: 111
The global Terbutaline Sulfate Tablets market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic lan...
2026-03-16 | Pages: 101 | Tables: 98
The global Pancreatin Enteric-Coated Capsules market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econo...
2026-03-16 | Pages: 112 | Tables: 117
The global Tomatine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report...
2026-03-16 | Pages: 91 | Tables: 100
The global Single Domain Antibody(sdAbs) Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global econ...
2026-03-16 | Pages: 118 | Tables: 125
The global L-Arginine and L-Citrulline Supplement market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global e...
2026-03-16 | Pages: 116 | Tables: 116
The global Glucosamine Sulfate API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landsca...
2026-03-16 | Pages: 118 | Tables: 123
The global Glucosamine Hydrochloride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic l...
2026-03-16 | Pages: 123 | Tables: 125
The global Self-replicating mRNA Vaccines market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic ...
2026-03-16 | Pages: 109 | Tables: 113
The global Circular mRNA Drugs market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. ...
2026-03-16 | Pages: 109 | Tables: 113
The global HIV and AIDS Vaccine market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape....
